FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to a contrast agent for magnetic-resonant tomography (MRT) based on a chemical exchange saturation transfer (CEST). The contrast agent contains polymersome provided by a paramagnetic substance, and a bilayer of an amphiphilic block copolymer or terpolymer comprising a cavity. In said cavity, there is a proton analyte pool containing water. The paramagnetic substance represents a paramagnetic chemical shift reagent containing a metal complex having a metal ion and a multidentate chelating ligand wherein the enclosure allows proton analyte diffusion. The invention also refers to a carrier of a drug preparation containing said contrast agent which is suitable for localised drug delivery. There is also declared a method for target MRT delivery of a bioactive substance into the patient which involves the stages of introducing the carrier of the drug preparation, performing MRT with using intensified CEST contrast, and enabling the carrier releasing the bioactive substance.
EFFECT: invention provides higher contrast, prolonged circulation and lesser tend to macrophage absorption.
9 cl, 7 dwg, 1 ex
Title | Year | Author | Number |
---|---|---|---|
DRUG CARRIER FOR CONTRAST ENHANCEMENT IN MRT | 2009 |
|
RU2528104C2 |
CHELATE AMPHIPHILIC POLYMERS | 2009 |
|
RU2519713C2 |
LIPID BILAYER CARRIER FOR MEDICINAL AND IMAGING AGENTS | 2011 |
|
RU2577291C2 |
CEST SYSTEMS PROVIDING SENSITIVITY NOT DEPENDING ON CONCENTRATION | 2011 |
|
RU2605823C2 |
ELIMINATION OF INVOLVEMENT OF CONTRAST AGENT CONCENTRATION IN MRT | 2007 |
|
RU2446829C2 |
CARRIERS FOR MPV-REGULATED DELIVERY OF MEDICATION, SENSITIVE TO STIMULATING FACTOR | 2010 |
|
RU2561035C2 |
GADOPENTETATE-MODIFIED BETA-CYCLODEXTRIN DERIVATIVES | 2013 |
|
RU2541090C1 |
WATER-DISPERSIBLE ORAL, ENTERAL AND LOCAL COMPOSITIONS FOR POORLY WATER-SOLUBLE DRUG PREPARATIONS CONTAINING POLYMER NANOPARTICLES IMPROVING PROPERTIES THEREOF | 2007 |
|
RU2492872C2 |
VECTORIZED WATER-COMPATIBLE POLYMER MICELLAR PARTICLES FOR DELIVERY OF BIOLOGICALLY ACTIVE SUBSTANCES THROUGH BLOOD-BRAIN BARRIER | 2020 |
|
RU2752177C1 |
METHOD FOR PREPARING A PREPARATION BASED ON MAGNETIC NANOPARTICLES (MNCH) OF IRON OXIDE FOR MRT-DIAGNOSIS OF NEOPLASMS | 2017 |
|
RU2659949C1 |
Authors
Dates
2013-03-10—Published
2008-12-04—Filed